ANI Pharmaceuticals Inc. (ANIP) - 5i Research

ANI Pharmaceuticals Inc. (ANIP $80.14)
- $80.14 Cap: $1.77B
- View ANIP Profile
- View Questions on ANIP

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Supernus Pharmaceuticals Inc. (SUPN $51.50)
- $51.50 Cap: $2.96B
- View SUPN Profile
- View Questions on SUPN
ANI Pharmaceuticals Inc. (ANIP $80.14)
- $80.14 Cap: $1.77B
- View ANIP Profile
- View Questions on ANIP

Q: Hi,
I am thinking to buy one of these.
What would be better buy and why?

Thank you.
Milan

Read Answer Asked by Milan on February 01, 2018

Lam Research Corporation (LRCX $258.76)
- $258.76 P/E (TTM): 46.07X Cap: $307.80B
- View LRCX Profile
- View Questions on LRCX
O'Reilly Automotive Inc. (ORLY $94.40)
- $94.40 P/E (TTM): 30.83X Cap: $78.98B
- View ORLY Profile
- View Questions on ORLY
ANI Pharmaceuticals Inc. (ANIP $80.14)
- $80.14 Cap: $1.77B
- View ANIP Profile
- View Questions on ANIP

Q: Your opinion on these 3 US stocks please?
1) LRCX
2) ANIP
3) ORLY

Read Answer Asked by Nino on January 23, 2018

Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!

First Name *

Last Name *

E-mail *

Password *

I have read and agree to the Terms of Use